In a highly collaborative and novel effort, the Kent lab has described the broad spectrum of autoreactivity of T cells that have infiltrated the islets of donors with Type 1 diabetes. This effort opens up our ability to directly examine the phenotype and function of the lymphocytes that are responsible for the destruction of insulin-producing beta cells in the pancreas in this autoimmune disease (Babon et al., Nature Medicine, 2016). To read more, click here.
The bionic pancreas system developed by Boston University (BU) investigators proved better than either conventional or sensor-augmented insulin pump therapy at managing blood sugar levels in patients with type 1 diabetes living at home, with no restrictions, over 11 days. The report of a clinical trial led by a Massachusetts General Hospital (MGH) along with three other institutions, including the University of Massachusetts Medical School DCOE, is receiving advance online publication in The Lancet.
The UMass Diabetes Center of Excellence (DCOE) is one of five institutions in the U.S. chosen by the Bringing Science Home for a collaborative training program to increase capacity in diabetes psychology. The program will train postdoctoral fellows for 1 year at 5 nationally recognized diabetes clinical research institutions: Stanford University, University of Chicago, Joslin Diabetes Center at Harvard University, University of Florida, and University of Massachusetts. According to Dr. Nicole Johnson, a well-known diabetes advocate, a member of the DCOE Visiting Advisory Committee, and the force behind this diabetes psychology training program, there is a serious need for more clinical psychologists who specialize in the management of chronic diseases, and this is especially the case in the field of diabetes.